🇺🇸 FDA
Patent

US 10138298

Anti-IL-2 antibodies and compositions and uses thereof

granted A61KA61K2039/505A61P

Quick answer

US patent 10138298 (Anti-IL-2 antibodies and compositions and uses thereof) held by The Regents of the University of California expires Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K2039/505, A61P, A61P29/00, A61P3/10